184 related articles for article (PubMed ID: 22921518)
1. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.
Kumar A; Wonganan P; Sandoval MA; Li X; Zhu S; Cui Z
J Control Release; 2012 Oct; 163(2):230-9. PubMed ID: 22921518
[TBL] [Abstract][Full Text] [Related]
2. Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11.
Santos DM; Carneiro MW; de Moura TR; Fukutani K; Clarencio J; Soto M; Espuelas S; Brodskyn C; Barral A; Barral-Netto M; de Oliveira CI
Int J Nanomedicine; 2012; 7():2115-27. PubMed ID: 22619548
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles.
Liu L; Ma P; Wang H; Zhang C; Sun H; Wang C; Song C; Leng X; Kong D; Ma G
J Control Release; 2016 Mar; 225():230-9. PubMed ID: 26826307
[TBL] [Abstract][Full Text] [Related]
4. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.
Kumar A; Li X; Sandoval MA; Rodriguez BL; Sloat BR; Cui Z
Int J Nanomedicine; 2011; 6():1253-64. PubMed ID: 21753877
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
[TBL] [Abstract][Full Text] [Related]
6. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
[TBL] [Abstract][Full Text] [Related]
7. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
[TBL] [Abstract][Full Text] [Related]
8. A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin.
Pamornpathomkul B; Wongkajornsilp A; Laiwattanapaisal W; Rojanarata T; Opanasopit P; Ngawhirunpat T
Int J Nanomedicine; 2017; 12():885-898. PubMed ID: 28184159
[TBL] [Abstract][Full Text] [Related]
9. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
[TBL] [Abstract][Full Text] [Related]
10. Microparticle delivery of plasmid DNA to mammalian cells.
Hedley ML; Barman SP
Methods Mol Biol; 2004; 245():265-86. PubMed ID: 14707387
[No Abstract] [Full Text] [Related]
11. Hepatitis B Antigen Loaded Biodegradable Polymeric Nanoparticles: Formulation Optimization and In-vivo Immunization in BALB/c Mice.
Dewangan HK; Singh S; Maurya L; Srivastava A
Curr Drug Deliv; 2018; 15(8):1204-1215. PubMed ID: 29866006
[TBL] [Abstract][Full Text] [Related]
12. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
13. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
14. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
Bershteyn A; Hanson MC; Crespo MP; Moon JJ; Li AV; Suh H; Irvine DJ
J Control Release; 2012 Feb; 157(3):354-65. PubMed ID: 21820024
[TBL] [Abstract][Full Text] [Related]
15. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
Gupta PN; Khatri K; Goyal AK; Mishra N; Vyas SP
J Drug Target; 2007 Dec; 15(10):701-13. PubMed ID: 18041638
[TBL] [Abstract][Full Text] [Related]
16. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
Díez S; Navarro G; de ILarduya CT
J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice.
Schipper P; van der Maaden K; Groeneveld V; Ruigrok M; Romeijn S; Uleman S; Oomens C; Kersten G; Jiskoot W; Bouwstra J
J Control Release; 2017 Sep; 262():28-36. PubMed ID: 28710002
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
Basarkar A; Devineni D; Palaniappan R; Singh J
Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
[TBL] [Abstract][Full Text] [Related]
19. Development of transdermal vitamin D3 (VD3) delivery system using combinations of PLGA nanoparticles and microneedles.
Kim HG; Gater DL; Kim YC
Drug Deliv Transl Res; 2018 Feb; 8(1):281-290. PubMed ID: 29247316
[TBL] [Abstract][Full Text] [Related]
20. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.
Cui Z; Mumper RJ
Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]